Search Orphan Drug Designations and Approvals
-
Generic Name: | Thymoxamine HCl |
---|---|
Date Designated: | 11/16/1987 |
Orphan Designation: | Reversal of phenylephrine-induced mydriasis in patients who have narrow anterior angles and are at risk of developing an acute attack of angle-closure glaucoma following mydriasis. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Iolab Pharmaceuticals 500 Iolab Drive Claremont, California 91711 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-